He spoke on the chances of getting popular weight loss drugs like Saxenda and Wegovy covered again for state employees, future premium increases and more. Briner announced soon after taking office ...

It comes as a Mail on Sunday investigation last week revealed almost 400 Brits had been hospitalised — some with ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

Novo Nordisk - which manufactures Wegovy, Ozempic and Saxenda - misreported, under-reported or did not disclose funding it ...

Lean mass constituted 30.8% of total body weight lost for adults who received a GLP-1 drug during a randomized controlled ...